urea and mdl 100907

urea has been researched along with mdl 100907 in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.41)	18.2507
2000's	6 (16.22)	29.6817
2010's	24 (64.86)	24.3611
2020's	5 (13.51)	2.80

Authors

Authors	Studies
Fuller, RW; Hemrick-Luecke, SK	1
Marcoli, M; Maura, G; Raiteri, M; Tortarolo, M	1
Ashby, CR; Katsumori, H; Minabe, Y; Watanabe, K	1
Pitsikas, N; Sakellaridis, N	1
Andersson, CM; Brann, MR; Burstein, ES; Davis, RE; Del Tredici, AL; Gardell, LR; Geyer, MA; Harvey, SC; Lameh, J; Makhay, M; Ott, TR; Piu, F; Powell, SB; Schiffer, HH; Schlienger, N; Son, TY; Thygesen, MB; Tolf, BR; Uldam, AK; Vanover, KE; Veinbergs, I; Weiner, DM	1
Ashby, CR; Blackburn, TP; Suzuki, K	1
Cai, L; Hertz, L; Li, B; Nu, W; Peng, L; Zhang, H; Zhang, S	1
Hertz, L; Li, B; Li, M; Peng, L; Zhang, S	1
Furness, JB; Gale, JD; Himaki, D; Kawai, M; Kurebayashi, Y; Nagao, K; Ohashi-Doi, K	1
Horiguchi, M; Huang, M; Li, Z; Meltzer, HY; Neill, JC; Shahid, M; Snigdha, S	1
Bai, CF; Cao, W; Guo, HJ; Liu, JC; Liu, SB; Yang, Q; Yi, DH; Zhang, XN; Zhao, MG; Zhao, R	1
Ancoli-Israel, S; Davis, RE; van Kammen, DP; Vanover, KE; Weiner, DM	1
Arnt, J; Ebdrup, BH; Glenthøj, B; Rasmussen, H	1
Bonhaus, DW; McFarland, K; Price, DL	2
Burt, AD; Douglass, A; Ebrahimkhani, MR; Ellis, E; Jaffré, F; Lakey, AF; Mann, DA; Mann, J; Maroteaux, L; Moles, A; Murphy, LB; Oakley, F; Perugorria, MJ; White, SA; Wright, MC	1
Klodt, PM; Kudrin, VS; Narkevich, VB; Raevskiĭ, KS	1
Hutcheson, JD; Merryman, WD; Ryzhova, LM; Setola, V	1
Hattori, T; Muto, S; Nahata, M; Nakagawa, K; Ohnishi, S; Sadakane, C; Saegusa, Y; Sakamoto, N; Takeda, H; Yamada, C	1
Meltzer, HY; Roth, BL	1
Banks, ML	1
Chi-Burris, K; Citrome, L; Demos, G; Norton, JC	1
Ondo, WG; Panchal, SC	1
Distler, JHW; Ensminger, SM; Gocht, A; Heim, C; Ramsperger-Gleixner, M; Spriewald, B; Weyand, M	1
Agarwal, V; Chaturvedi, S; Misra, DP; Prasad, N; Rai, MK; Rastogi, K; Singh, H	1
Jalal, B	1
Ballard, C; Cummings, J; Foff, E; Norton, J; Owen, R; Stankovic, S; Tariot, P; Youakim, J	1
Ballard, C; Coate, B; Stankovic, S; Youakim, JM	1
Adler, CH; Alva, G; Black, KJ; Cooney, JW; Isaacson, S; Kremens, D; Menza, MA; Meyer, JM; Morrissette, DA; Nasrallah, H; Pahwa, R; Patkar, AA; Simuni, T; Stacy, M; Stahl, SM	1
Canal, C; de la Cruz, J	1
Fedora, R; Morton, R; Nasrallah, HA	1
Boren, CB; Boren, RA	1
Coate, B; Isaacson, SH; Norton, J; Stankovic, S	1
Abler, V; Aldred, JL; Alva, G; Cantillon, M; Coate, B; DeKarske, D; Jacobi, L; Norton, JC; Nunez, R	1
Dirks, B; Fava, M; Freeman, MP; Jha, MK; Liu, K; Papakostas, GI; Shelton, RC; Stankovic, S; Thase, ME; Trivedi, MH	1
Atanasovski, D; Eriksson, E; Hagsäter, SM; Näslund, J; Pettersson, C; Pettersson, R	1
Abbs, B; Arango, C; Bugarski-Kirola, D; Fava, M; Liu, IY; Nasrallah, H; Stankovic, S	1

Reviews

7 review(s) available for urea and mdl 100907

Article	Year
Serotonin 2A receptor antagonists for treatment of schizophrenia. Expert opinion on investigational drugs, 2011, Volume: 20, Issue:9 Topics: Antipsychotic Agents; Brain; Fluorobenzenes; Humans; Phenols; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Urea	2011
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs. The Journal of clinical investigation, 2013, Volume: 123, Issue:12 Topics: Benzazepines; Diabetes Mellitus, Type 2; Heart Valve Diseases; Humans; Molecular Structure; Obesity; Parkinson Disease; Piperidines; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Urea	2013
Pimavanserin for the treatment of Parkinson's disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed. CNS spectrums, 2018, Volume: 23, Issue:3 Topics: Clinical Trials as Topic; Humans; Numbers Needed To Treat; Parkinson Disease; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Urea	2018
Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis. Current psychiatry reports, 2018, 01-27, Volume: 20, Issue:1 Topics: Antipsychotic Agents; Delusions; Hallucinations; Humans; Parkinson Disease; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Urea	2018
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology, 2018, Volume: 235, Issue:11 Topics: Animals; Dopamine; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neuropharmacology; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sleep; Sleep Paralysis; Urea	2018
Pimavanserin: Potential Treatment For Dementia-Related Psychosis. The journal of prevention of Alzheimer's disease, 2018, Volume: 5, Issue:4 Topics: Alzheimer Disease; Clinical Trials as Topic; Dementia; Humans; Mental Status and Dementia Tests; Parkinson Disease; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Severity of Illness Index; Treatment Outcome; Urea	2018
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. CNS spectrums, 2018, Volume: 23, Issue:6 Topics: Antiparkinson Agents; Antipsychotic Agents; Consensus; Drug Substitution; Humans; Off-Label Use; Parkinson Disease; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Urea	2018

Trials

6 trial(s) available for urea and mdl 100907

Article	Year
Pimavanserin tartrate, a 5-HT(2A) receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers. Sleep medicine, 2011, Volume: 12, Issue:2 Topics: Adult; Aged; Double-Blind Method; Female; Human Experimentation; Humans; Male; Middle Aged; Patient Compliance; Piperidines; Placebo Effect; Polysomnography; Serotonin 5-HT2 Receptor Antagonists; Sleep; Urea	2011
Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms. The journal of prevention of Alzheimer's disease, 2019, Volume: 6, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Nursing Homes; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome; Urea	2019
Blinded SAPS-PD Assessment After 10 Weeks of Pimavanserin Treatment for Parkinson's Disease Psychosis. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Urea	2020
An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Piperidines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin and Noradrenaline Reuptake Inhibitors; Urea	2020
Effect of Adjunctive Pimavanserin on Sleep/Wakefulness in Patients With Major Depressive Disorder: Secondary Analysis From CLARITY. The Journal of clinical psychiatry, 2020, 12-01, Volume: 82, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linear Models; Male; Middle Aged; Piperidines; Serotonin 5-HT2 Receptor Antagonists; Sleep Wake Disorders; Treatment Outcome; Urea; Young Adult	2020
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe. The lancet. Psychiatry, 2022, Volume: 9, Issue:1 Topics: Adolescent; Adult; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; North America; Outcome Assessment, Health Care; Piperidines; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Urea; Young Adult	2022

Other Studies

24 other study(ies) available for urea and mdl 100907

Article	Year
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212. European journal of pharmacology, 1996, Sep-12, Volume: 311, Issue:2-3 Topics: Animals; Corticosterone; Fluorobenzenes; Indoles; Male; Piperidines; Pyrazines; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Urea	1996
Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum: involvement of 5-hydroxytryptamine2C receptors. Journal of neurochemistry, 1997, Volume: 69, Issue:1 Topics: Adrenergic alpha-Antagonists; Animals; Cerebellum; Cyclic GMP; Excitatory Amino Acid Agonists; Fluorobenzenes; Indoles; Male; N-Methylaspartate; Nitric Oxide; Organ Culture Techniques; Phenols; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Urea; Yohimbine	1997
The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. European journal of pharmacology, 2000, Jun-16, Volume: 398, Issue:2 Topics: Animals; Dose-Response Relationship, Drug; Electroencephalography; Fluorobenzenes; Granisetron; Hippocampus; Indoles; Locomotion; Male; Piperazines; Piperidines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Seizures; Serotonin Antagonists; Severity of Illness Index; Urea	2000
The 5-HT2C receptor antagonist RO 60-0491 counteracts rats' retention deficits in a recognition memory task. Brain research, 2005, Aug-30, Volume: 1054, Issue:2 Topics: Animals; Behavior, Animal; Discrimination, Psychological; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Motor Activity; Naphthalenes; Rats; Rats, Wistar; Recognition, Psychology; Retention, Psychology; Serotonin 5-HT2 Receptor Antagonists; Urea	2005
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 317, Issue:2 Topics: Animals; Behavior, Animal; Biological Availability; Cloning, Molecular; Humans; Male; Mice; NIH 3T3 Cells; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Urea	2006
The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study. Synapse (New York, N.Y.), 2006, Jun-15, Volume: 59, Issue:8 Topics: Action Potentials; Animals; Dopamine; Electrophysiology; Indoles; Male; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Time Factors; Urea	2006
Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology, 2008, Volume: 201, Issue:3 Topics: Aminopyridines; Animals; Antidepressive Agents, Second-Generation; Astrocytes; Butadienes; Calcium; Cells, Cultured; Chelating Agents; Dipeptides; Dose-Response Relationship, Drug; Egtazic Acid; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fluorobenzenes; Fluoxetine; Gene Expression; Indoles; Maleimides; Mice; Nitriles; Phosphorylation; Piperidines; Protein Kinase C; Proto-Oncogene Proteins c-fos; Quinazolines; Receptor, Serotonin, 5-HT2B; RNA, Messenger; Signal Transduction; Substrate Specificity; Transcriptional Activation; Tyrphostins; Up-Regulation; Urea	2008
Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology, 2009, Volume: 207, Issue:1 Topics: Animals; Astrocytes; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Gene Expression Regulation; Indoles; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phospholipases A2; Phosphorylation; Receptor, Serotonin, 5-HT2B; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Time Factors; Urea	2009
A selective, high affinity 5-HT 2B receptor antagonist inhibits visceral hypersensitivity in rats. Neurogastroenterology and motility, 2010, Volume: 22, Issue:2 Topics: Analysis of Variance; Animals; Colon; Dose-Response Relationship, Drug; Hypersensitivity; Indoles; Inflammation; Male; Muscle Contraction; Muscle, Smooth; Pain Measurement; Pain Threshold; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Restraint, Physical; Serotonin 5-HT2 Receptor Antagonists; Statistics, Nonparametric; Stress, Physiological; Trinitrobenzenesulfonic Acid; Urea	2010
Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:2 Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Drug Interactions; Drug Inverse Agonism; Female; Fluorobenzenes; Phencyclidine; Piperidines; Random Allocation; Rats; Rats, Long-Evans; Recognition, Psychology; Serotonin 5-HT2 Receptor Antagonists; Urea	2010
Role of 5-HT 2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Calcium Channels, L-Type; Cardiomegaly; Cardiomyopathies; Caspase 3; Down-Regulation; Indoles; Myocytes, Cardiac; Naphthyridines; Norepinephrine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Up-Regulation; Urea	2010
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease. Behavioural pharmacology, 2011, Volume: 22, Issue:7 Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dyskinesias; Fenfluramine; Fluorobenzenes; Hyperkinesis; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Psychotic Disorders; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase; Urea	2011
Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nature medicine, 2011, Nov-27, Volume: 17, Issue:12 Topics: Animals; Cell Proliferation; Cells, Cultured; Chronic Disease; Electrophoresis, Polyacrylamide Gel; Hepatic Stellate Cells; Hepatocytes; Immunohistochemistry; Indoles; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Transforming Growth Factor beta1; Urea; Wound Healing	2011
[Possible role of serotonin 5-HT2 receptors in mechanism of afobazole anxiolytic action: neurochemical study of inter-line differences in mice]. Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:12 Topics: Animals; Anti-Anxiety Agents; Benzimidazoles; Biogenic Monoamines; Brain Chemistry; Drug Synergism; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholines; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Antagonists; Species Specificity; Urea	2011
Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease. Behavioural pharmacology, 2012, Volume: 23, Issue:4 Topics: Alzheimer Disease; Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Drug Inverse Agonism; Male; Mice; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Urea	2012
5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation. Journal of molecular and cellular cardiology, 2012, Volume: 53, Issue:5 Topics: Actins; Animals; Aortic Diseases; Aortic Valve; Calcinosis; Cell Differentiation; Cells, Cultured; Gene Expression; Indoles; Microfilament Proteins; Muscle Proteins; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Protein Processing, Post-Translational; Protein Transport; Pyridines; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Smad3 Protein; src-Family Kinases; Sus scrofa; Transcriptional Activation; Transforming Growth Factor beta1; Urea	2012
Rikkunshito, a Japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model. BioMed research international, 2013, Volume: 2013 Topics: Animals; Behavior, Animal; Chalcones; Drugs, Chinese Herbal; Eating; Enzyme Inhibitors; Feeding Behavior; Ghrelin; Humans; Indoles; Male; Medicine, Kampo; Mice; Quinolines; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Stress, Psychological; Urea	2013
Effects of 7-day repeated treatment with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in male rhesus monkeys. Drug and alcohol dependence, 2016, Aug-01, Volume: 165 Topics: Animals; Choice Behavior; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Inverse Agonism; Feeding Behavior; Food; Macaca mulatta; Male; Methamphetamine; Piperidines; Reinforcement, Psychology; Self Administration; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome; Urea	2016
Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts. Transplant immunology, 2018, Volume: 49 Topics: Animals; Aorta; Cell Proliferation; Female; Graft Rejection; Heart Transplantation; Humans; Indoles; Lisuride; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Models, Animal; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Succinates; Transendothelial and Transepithelial Migration; Transplantation, Homologous; Urea	2018
5-HT International journal of rheumatic diseases, 2018, Volume: 21, Issue:12 Topics: Adult; Cells, Cultured; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Indoles; Lisuride; Phenotype; Phosphorylation; Receptor, Serotonin, 5-HT2B; Scleroderma, Systemic; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Skin; STAT3 Transcription Factor; Transforming Growth Factor beta1; Urea	2018
Can pimavanserin help patients with Parkinson disease psychosis? JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:1 Topics: Antipsychotic Agents; Humans; Parkinson Disease; Piperidines; Psychotic Disorders; Serotonin 5-HT2 Receptor Antagonists; Urea	2019
Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist. Schizophrenia research, 2019, Volume: 208 Topics: Adult; Aged; Antipsychotic Agents; Clozapine; Delusions; Drug Resistance; Female; Hallucinations; Humans; Male; Middle Aged; Piperidines; Psychotic Disorders; Retrospective Studies; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Urea; Young Adult	2019
Charles Bonnet Syndrome Treated With Pimavanserin. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2019, Volume: 39, Issue:4 Topics: Aged, 80 and over; Charles Bonnet Syndrome; Humans; Male; Piperidines; Serotonin 5-HT2 Receptor Antagonists; Urea	2019
A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear. The international journal of neuropsychopharmacology, 2021, 09-21, Volume: 24, Issue:9 Topics: Animals; Behavior, Animal; Bridged Bicyclo Compounds; Conditioning, Classical; Fear; Fluorobenzenes; Ligands; Male; Methylamines; Piperidines; Psilocybin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Urea	2021